Overall, knockdown of AGTPBP1 enhanced the oncogenic characteristics, including proliferation, migration, self-renewal, and drug-resistance, of A549 lung cancer cells, suggesting that AGTPBP1 had a tumor-suppressing ability and could modulate the progression of LUAD. The gene discussed is AGTPBP1; the disease is lung cancer.